QSE 8 — Internal and External Assessments
8.0 Internal and External Assessments
The organization shall conduct assessments of operations and quality systems.
Chapter 8 aims to ensure that the quality management system is effective and provides an opportunity for improvement. The laboratory has two obligations under the requirements in this chapter: internal and external assessments. (SS)
The committee revised standard 8.0 based on updates to the AABB Quality System Essentials. (SC)
8.1 Internal Assessments
[Cord blood applicable]
The organization shall conduct internal assessments. Internal assessments shall be performed by personnel independent of those having direct responsibility for the activity being assessed.
Internal assessments should be scheduled on the basis of the significance of the activity to be assessed. These CT Standards do not establish a specific schedule; the facility should review its operations and determine what schedule is appropriate. It is recommended that all activities that constitute the quality system be assessed once a year. During the first 2 to 3 years of implementation of a quality management system, however, it is recommended that the quality system be assessed more frequently (eg, at 3- to 6- month intervals). As a general rule, critical activities should be assessed frequently, and areas with consistent problems should be assessed often until there is clear resolution of the problems.
These internal assessments should evaluate both operational and quality system activities. It is acceptable to use the AABB Assessment Tools (eg, Cellular Therapy Services Standards Assessment Tool, available to members) as a guide for these assessments.
Ideally, individuals who assess specific activities should be independent from those having direct responsibility for the activity. However, this independence may not always be possible. Accordingly, independence may be interpreted as employees from the same department who assess one another’s work.
The facility should determine how often specific departments will be assessed and identify when they will be assessed. When the internal assessors have been identified, they need to be trained. External courses provide a training option, or a large organization may choose to provide internal training for a group of assessors. Regardless of where it takes place, assessment training should focus on the general structure of the quality system, understanding of auditing techniques, and good communication. Assessors should use a systems approach rather than depending on a predictable checklist of standard questions. Assessors can assess all departments at one time or may choose to develop a schedule in which departments are assessed, one at a time, throughout the year.
A “life of a product” assessment is another option. All procedures involved from the initial assessment/scheduling of the patient (eg, informed consent process) to the collection, preparation, labeling, any storage, and final disposition of the product, including reviewing of records related to quality assessments of personnel, products, and equipment used in the procedures, are audited. The program’s policies, processes, and procedures should describe the internal assessment process. (SS)
The committee revised standard 8.1 based on updates to the AABB Quality System Essentials. (SC)
8.2 External Assessments
[Cord blood applicable]
The organization shall participate in an external assessment program applicable to the activities performed in the organization.
The facility must ensure that external assessments are obtained at appropriately defined intervals. External assessments may be provided by organizations such as AABB, The Joint Commission, and the College of American Pathologists. The results of the external assessments should be reviewed by executive management. (SS)
8.3 Management of Assessment Results
[Cord blood applicable]
The results of assessments shall be:
- Reviewed by the personnel having responsibility for the area assessed.
- Evaluated to determine the need for corrective and preventive action.
- Communicated to the appropriate staff.
- Reported to executive management.
The results of all assessments are required to be brought to the attention of executive management for review and sign-off and to individuals who have responsibility for the activity. Management personnel are responsible for implementing timely corrective and preventive actions for each identified nonconformance, as required in Chapter 9, Process Improvement. (SS)
8.4 Quality Monitoring
The organization shall collect and evaluate quality indicator data on a scheduled basis, including adverse events.
Executive management should define quality indicators on an ongoing basis. Data should be collected to support that quality indicators are met. Data should be collected and provided to executive management to ensure that the quality indicators are met. Periodic review of the data should be shared with the applicable quality review committee.
Examples of data that can be used as quality indicators for facility services may include, but are not limited to:
- Customer feedback.
- Audits.
- Deviations.
- Exceptions.
- Personnel training.
- Evaluations of personnel competency.
- Equipment calibration and validation.
- Vendor qualification of supplies and reagents.
- Standard operating procedure review and evaluation.
- Turnaround time for reported results.
- Product traceability (including chain of custody). (SS)
The committee reviewed this comment but did not feel that a change was needed at this time. The committee noted that standard 5.9 already covers what is requested in the comment. (SC)
8.4.1
The organization shall provide data generated to the personnel who have responsibility for the quality indicator data collected.
The committee added standard 8.4.1 based on updates to the AABB Quality System Essentials. (SC)
8.5 Monitoring Clinical Activities
[Cord blood applicable]
Facilities performing clinical activities shall have a program that addresses, evaluates, and monitors patient care practices for all cellular therapies. The following shall be monitored:
- Ordering practices.
- Patient identification.
- Sample collection and labeling.
- Medication errors.
- Near-miss events.
- Adverse events.
- Ability of services to meet patient needs.
- Compliance with peer-reviewed recommendations.
- Adherence to research protocols or investigator’s brochures, if applicable.
- Critical process points (eg, hand-offs, confirmation of patient identification before medical intervention) for conformance with policies, processes, procedures, and protocols.
Executive management should define quality objectives on an ongoing basis. Data should be collected to support that the quality objectives are met. Quality indicator data should be collected and provided to executive management to ensure that the quality objectives are met. Periodic review of the data should be shared with the applicable quality review committee. (SS)
Excerpt of Reference Standard 6.2.9A Relevant to Internal and External Assessments
| Standard | Record to Be Maintained | Quality System Records | Donor Eligibility/Management Issues | Unit/Recipient |
Retention after Creation (C) or Final Disposition (F) of Related Product |
Minimum Retention Time (in years)1 |
| 8.1 | Internal assessments | X | X | X | C | 10 |
| 8.2 | External assessments | X | X | X | C | 10 |
| 8.3 |
Management of assessment results |
X | X | X | C | 10 |
| 8.5 | Monitoring of clinical activities | X | X | X | C | 10 |
1Applicable federal, state, or local law may exceed this period.